NA Tumor Ablation Market - Industry Trends and Forecast to 2030

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	163 Pages	Data Bridge Market Research	January, 2023	DAABD18146413

Best Price Guarantee
Price	from $3,500
Length	163 Pages
Publisher	Data Bridge Market Research
Published Date	January, 2023
SKU	DAABD18146413

NA Tumor Ablation Market - Industry Trends and Forecast to 2030

North America Tumor Ablation Market is expected to reach USD 1,799.45 Million by 2030 from USD 564.81 Million in 2022, growing at a CAGR of 15.6% during the forecast period of 2023 to 2030.

Market Segmentation
North America Tumor Ablation Market, By Type (Thermal Ablation, and Chemical Ablation), Types of Treatment (Percutaneous, Laparoscopic, and Surgical), Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Liver Cancer, Kidney Cancer, Bone Cancer, and Others), End Users (Hospitals, Oncology Centers, and Others), Distribution Channel (Direct Tender, and Retail Sales), Country (U.S., Canada, and Mexico)- Industry Trends and Forecast to 2030

Overview of North America Tumor Ablation Market Dynamics

Driver

• Increasing inclination of surgeons and patients towards minimally invasive procedures

Restraint

• Limited clinical evidence

Opportunity

• Rising healthcare expenditure

Market Players

Some of the key players operating in the North America tumor ablation market are
• Boston Scientific Corporation
• Medtronic
• Olympus
• Stryker
• Biotronik
• AngioDynamics
• Bioventus LLC.
• BVM Medical Limited
• EDAP TMS
• Ethicon, Inc.
• HealthTronics, Inc.
• IceCure Medical
• Insightec
• Integra LifeSciences
• Merit Medical Systems
• Sonablate Corp.
• Terumo Europe NV

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. These report will take approximately 15-20 business days to prepare and deliver.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of The North America Tumor Ablation Market; 1.4 Currency And Pricing; 1.5 Limitations; 1.6 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Dbmr Tripod Data Validation Model; 2.5 Primary Interviews With Key Opinion Leaders; 2.6 Multivariate Modelling; 2.7 Type Segment Lifeline Curve; 2.8 Market End Users Coverage Grid; 2.9 Dbmr Market Position Grid; 2.10 Vendor Share Analysis; 2.11 Secondary Sources; 2.12 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Pestel Analysis; 4.2 Porter's Five Forces Model
5 Regulatory Framework: 5.1 Regulatory Scenario In The U.S
6 Market Overview: 6.1 Drivers; 6.1.1 Rising Prevalence Of Cancer North Americaly; 6.1.2 Increasing Inclination Of Surgeons And Patients Toward Minimally Invasive Procedures; 6.1.3 Rising Technological Advancements; 6.1.4 Increasing Awareness And Education; 6.2 Restraints; 6.2.1 Regulatory Hurdles For Approval; 6.2.2 Limited Clinical Evidence; 6.3 Opportunities; 6.3.1 Favorable Reimbursement Scenario; 6.3.2 Strategic Initiatives By Major Market Players; 6.4 Challenges; 6.4.1 Technical Challenges In Targeting The Tumor; 6.4.2 Competition From Alternative Treatment Modalities
7 North America Tumor Ablation Market, By Type: 7.1 Overview; 7.2 Thermal Ablation; 7.2.1 Tumor Ablation Systems; 7.2.1.1 Radiofrequency; 7.2.1.1.1 Bipolar; 7.2.1.1.2 Multipolar; 7.2.2 Image Guidance Products And Accessories; 7.2.2.1 Ct; 7.2.2.2 Mr Imaging; 7.2.2.3 Fluoroscopy; 7.2.2.4 Others; 7.2.2.5 Microwave; 7.2.2.6 Cryoablation; 7.2.2.7 High-intensity Focused Ultrasound (Hifu); 7.2.2.8 Laser; 7.3 Chemical Ablation; 7.3.1 Ethanol; 7.3.2 Acetic Acid
8 North America Tumor Ablation Market, By Types Of Treatment: 8.1 Overview; 8.2 Percutaneous; 8.2.1 Breast Cancer; 8.2.2 Lung Cancer; 8.2.3 Prostate Cancer; 8.2.4 Liver Cancer; 8.2.5 Kidney Cancer; 8.2.6 Other Cancers 80; 8.3 Laparoscopy; 8.3.1 Breast Cancer; 8.3.2 Lung Cancer; 8.3.3 Prostate Cancer; 8.3.4 Liver Cancer; 8.3.5 Kidney Cancer; 8.3.6 Other Cancers; 8.4 Surgical; 8.4.1 Breast Cancer; 8.4.2 Lung Cancer; 8.4.3 Prostate Cancer; 8.4.4 Liver Cancer; 8.4.5 Kidney Cancer; 8.4.6 Other Cancers
9 North America Tumor Ablation Market, By Cancer Type: 9.1 Overview; 9.2 Breast Cancer; 9.3 Lung Cancer; 9.4 Prostate Cancer; 9.5 Liver Cancer; 9.6 Kidney Cancer; 9.7 Bone Cancer; 9.8 Others
10 North America Tumor Ablation Market, By End Users: 10.1 Overview; 10.2 Hospitals; 10.3 Oncology Centers; 10.4 Others
11 North America Tumor Ablation Market, By Distribution Channel: 11.1 Overview; 11.2 Direct Tender; 11.3 Retail Sales
12 North America Tumor Ablation Market, By Region: 12.1 North America; 12.1.1 U.S.; 12.1.2 Canada; 12.1.3 Mexico
13 North America Tumor Ablation Market, Company Landscape: 13.1 Company Share Analysis: North America
14 Swot Analysis
15 Company Profile: 15.1 Boston Scientific Corporation; 15.1.1 Company Snapshot; 15.1.2 Revenue Analysis; 15.1.3 Company Share Analysis; 15.1.4 Product Portfolio; 15.1.5 Recent Development; 15.2 Medtronic; 15.2.1 Company Snapshot; 15.2.2 Revenue Analysis; 15.2.3 Company Share Analysis; 15.2.4 Product Portfolio; 15.2.5 Recent Development; 15.3 Olympus; 15.3.1 Company Snapshot; 15.3.2 Revenue Analysis; 15.3.3 Company Share Analysis; 15.3.4 Product Portfolio; 15.3.5 Recent Development; 15.4 Stryker; 15.4.1 Company Snapshot; 15.4.2 Revenue Analysis; 15.4.3 Company Share Analysis; 15.4.4 Product Portfolio; 15.4.5 Recent Development; 15.5 Biotronik; 15.5.1 Company Snapshot; 15.5.2 Company Share Analysis; 15.5.3 Product Portfolio; 15.5.4 Recent Development; 15.6 Angiodynamics.; 15.6.1 Company Snapshot; 15.6.2 Revenue Analysis; 15.6.3 Product Portfolio; 15.6.4 Recent Development; 15.7 Bioventus Llc.; 15.7.1 Company Snapshot; 15.7.2 Product Portfolio; 15.7.3 Recent Development; 15.8 Bvm Medical Limited; 15.8.1 Company Snapshot; 15.8.2 Product Portfolio; 15.8.3 Recent Development; 15.9 Edap Tms; 15.9.1 Company Snapshot; 15.9.2 Revenue Analysis; 15.9.3 Product Portfolio; 15.9.4 Recent Development; 15.10 Ethicon, Inc.; 15.10.1 Company Snapshot; 15.10.2 Product Portfolio; 15.10.3 Recent Development; 15.11 Healthtronics, Inc.; 15.11.1 Company Snapshot; 15.11.2 Product Portfolio; 15.11.3 Recent Development; 15.12 Icecure Medical; 15.12.1 Company Snapshot; 15.12.2 Revenue Analysis; 15.12.3 Product Portfolio; 15.12.4 Recent Development; 15.13 Insightec.; 15.13.1 Company Snapshot; 15.13.2 Product Portfolio; 15.13.3 Recent Development; 15.14 Integra Lifesciences; 15.14.1 Company Snapshot; 15.14.2 Revenue Analysis; 15.14.3 Product Portfolio; 15.14.4 Recent Development; 15.15 Merit Medical Systems.; 15.15.1 Company Snapshot; 15.15.2 Revenue Analysis; 15.15.3 Product Portfolio; 15.15.4 Recent Development; 15.16 Sonablate Corp.; 15.16.1 Company Snapshot; 15.16.2 Product Portfolio; 15.16.3 Recent Development; 15.17 Terumo Europe Nv; 15.17.1 Company Snapshot; 15.17.2 Product Portfolio; 15.17.3 Recent Development
16 Questionnaire
17 Related Reports
List Of Tables: Table 1 North America Tumor Ablation Market, By Type, 2021-2030 (Usd Million); Table 2 North America Thermal Ablation In Tumor Ablation Market, By Region, 2021-2030 (Usd Million); Table 3 North America Thermal Ablation In Tumor Ablation Market, By Type, 2021-2030 (Usd Million); Table 4 North America Tumor Ablation Systems In Tumor Ablation Market, By Type, 2021-2030 (Usd Million); Table 5 North America Radiofrequency In Tumor Ablation Market, By Type, 2021-2030 (Usd Million); Table 6 North America Image Guidance Products And Accessories In Tumor Ablation Market, By Type, 2021-2030 (Usd Million); Table 7 North America Chemical Ablation In Tumor Ablation Market, By Region, 2021-2030 (Usd Million); Table 8 North America Chemical Ablation In Tumor Ablation Market, By Type, 2021-2030 (Usd Million); Table 9 North America Tumor Ablation Market, By Types Of Treatment, 2021-2030 (Usd Million); Table 10 North America Percutaneous In Tumor Ablation Market, By Region, 2021-2030 (Usd Million); Table 11 North America Percutaneous In Tumor Ablation Market, By Cancer Type, 2021-2030 (Usd Million); Table 12 North America Laparoscopic In Tumor Ablation Market, By Region, 2021-2030 (Usd Million); Table 13 North America Laproscopic In Tumor Ablation Market, By Cancer Type, 2021-2030 (Usd Million); Table 14 North America Surgical In Tumor Ablation Market, By Region, 2021-2030 (Usd Million); Table 15 North America Surgical In Tumor Ablation Market, By Cancer Type, 2021-2030 (Usd Million); Table 16 North America Tumor Ablation Market, By Cancer Type, 2021-2030 (Usd Million); Table 17 North America Breast Cancer In Tumor Ablation Market, By Region, 2021-2030 (Usd Million); Table 18 North America Lung Cancer In Tumor Ablation Market, By Region, 2021-2030 (Usd Million); Table 19 North America Prostate Cancer In Tumor Ablation Market, By Region, 2021-2030 (Usd Million); Table 20 North America Liver Cancer In Tumor Ablation Market, By Region, 2021-2030 (Usd Million); Table 21 North America Kidney Cancer In Tumor Ablation Market, By Region, 2021-2030 (Usd Million); Table 22 North America Bone Cancer In Tumor Ablation Market, By Region, 2021-2030 (Usd Million); Table 23 North America Others In Tumor Ablation Market, By Region, 2021-2030 (Usd Million); Table 24 North America Tumor Ablation Market, By End Users, 2021-2030 (Usd Million); Table 25 North America Hospitals In Tumor Ablation Market, By Region, 2021-2030 (Usd Million); Table 26 North America Oncology Centers In Tumor Ablation Market, By Region, 2021-2030 (Usd Million); Table 27 North America Others In Tumor Ablation Market, By Region, 2021-2030 (Usd Million); Table 28 North America Tumor Ablation Market, By Distribution Channel, 2021-2030 (Usd Million); Table 29 North America Direct Tender In Tumor Ablation Market, By Region, 2021-2030 (Usd Million); Table 30 North America Retail Sales In Tumor Ablation Market, By Region, 2021-2030 (Usd Million); Table 31 North America Tumor Ablation Market, By Country, 2021-2030 (Usd Million); Table 32 North America Tumor Ablation Market, By Type, 2021-2030 (Usd Million); Table 33 North America Thermal Ablation In Tumor Ablation Market, By Type, 2021-2030 (Usd Million); Table 34 North America Tumor Ablation Systems In Tumor Ablation Market, By Type, 2021-2030 (Usd Million); Table 35 North America Radiofrequency In Tumor Ablation Market, By Type, 2021-2030 (Usd Million); Table 36 North America Image Guidance Products And Accessories In Tumor Ablation Market, By Type, 2021-2030 (Usd Million); Table 37 North America Chemical Ablation In Tumor Ablation Market, By Type, 2021-2030 (Usd Million); Table 38 North America Tumor Ablation Market, By Types Of Treatment, 2021-2030 (Usd Million); Table 39 North America Percutaneous In Tumor Ablation Market, By Cancer Type, 2021-2030 (Usd Million); Table 40 North America Laproscopic In Tumor Ablation Market, By Cancer Type, 2021-2030 (Usd Million); Table 41 North America Surgical In Tumor Ablation Market, By Cancer Type, 2021-2030 (Usd Million); Table 42 North America Tumor Ablation Market, By Cancer Type, 2021-2030 (Usd Million); Table 43 North America Tumor Ablation Market, By End Users, 2021-2030 (Usd Million); Table 44 North America Tumor Ablation Market, By Distribution Channel, 2021-2030 (Usd Million); Table 45 U.S. Tumor Ablation Market, By Type, 2021-2030 (Usd Million); Table 46 U.S. Thermal Ablation In Tumor Ablation Market, By Type, 2021-2030 (Usd Million); Table 47 U.S. Tumor Ablation Systems In Tumor Ablation Market, By Type, 2021-2030 (Usd Million); Table 48 U.S. Radiofrequency In Tumor Ablation Market, By Type, 2021-2030 (Usd Million); Table 49 U.S. Image Guidance Products And Accessories In Tumor Ablation Market, By Type, 2021-2030 (Usd Million); Table 50 U.S. Chemical Ablation In Tumor Ablation Market, By Type, 2021-2030 (Usd Million); Table 51 U.S. Tumor Ablation Market, By Types Of Treatment, 2021-2030 (Usd Million); Table 52 U.S. Percutaneous In Tumor Ablation Market, By Cancer Type, 2021-2030 (Usd Million); Table 53 U.S. Laproscopic In Tumor Ablation Market, By Cancer Type, 2021-2030 (Usd Million); Table 54 U.S. Surgical In Tumor Ablation Market, By Cancer Type, 2021-2030 (Usd Million); Table 55 U.S. Tumor Ablation Market, By Cancer Type, 2021-2030 (Usd Million); Table 56 U.S. Tumor Ablation Market, By End Users, 2021-2030 (Usd Million); Table 57 U.S. Tumor Ablation Market, By Distribution Channel, 2021-2030 (Usd Million); Table 58 Canada Tumor Ablation Market, By Type, 2021-2030 (Usd Million); Table 59 Canada Thermal Ablation In Tumor Ablation Market, By Type, 2021-2030 (Usd Million); Table 60 Canada Tumor Ablation Systems In Tumor Ablation Market, By Type, 2021-2030 (Usd Million); Table 61 Canada Radiofrequency In Tumor Ablation Market, By Type, 2021-2030 (Usd Million); Table 62 Canada Image Guidance Products And Accessories In Tumor Ablation Market, By Type, 2021-2030 (Usd Million); Table 63 Canada Chemical Ablation In Tumor Ablation Market, By Type, 2021-2030 (Usd Million); Table 64 Canada Tumor Ablation Market, By Types Of Treatment, 2021-2030 (Usd Million); Table 65 Canada Percutaneous In Tumor Ablation Market, By Cancer Type, 2021-2030 (Usd Million); Table 66 Canada Laproscopic In Tumor Ablation Market, By Cancer Type, 2021-2030 (Usd Million); Table 67 Canada Surgical In Tumor Ablation Market, By Cancer Type, 2021-2030 (Usd Million); Table 68 Canada Tumor Ablation Market, By Cancer Type, 2021-2030 (Usd Million); Table 69 Canada Tumor Ablation Market, By End Users, 2021-2030 (Usd Million); Table 70 Canada Tumor Ablation Market, By Distribution Channel, 2021-2030 (Usd Million); Table 71 Mexico Tumor Ablation Market, By Type, 2021-2030 (Usd Million); Table 72 Mexico Thermal Ablation In Tumor Ablation Market, By Type, 2021-2030 (Usd Million); Table 73 Mexico Tumor Ablation Systems In Tumor Ablation Market, By Type, 2021-2030 (Usd Million); Table 74 Mexico Radiofrequency In Tumor Ablation Market, By Type, 2021-2030 (Usd Million); Table 75 Mexico Image Guidance Products And Accessories In Tumor Ablation Market, By Type, 2021-2030 (Usd Million); Table 76 Mexico Chemical Ablation In Tumor Ablation Market, By Type, 2021-2030 (Usd Million); Table 77 Mexico Tumor Ablation Market, By Types Of Treatment, 2021-2030 (Usd Million); Table 78 Mexico Percutaneous In Tumor Ablation Market, By Cancer Type, 2021-2030 (Usd Million); Table 79 Mexico Laproscopic In Tumor Ablation Market, By Cancer Type, 2021-2030 (Usd Million); Table 80 Mexico Surgical In Tumor Ablation Market, By Cancer Type, 2021-2030 (Usd Million); Table 81 Mexico Tumor Ablation Market, By Cancer Type, 2021-2030 (Usd Million); Table 82 Mexico Tumor Ablation Market, By End Users, 2021-2030 (Usd Million); Table 83 Mexico Tumor Ablation Market, By Distribution Channel, 2021-2030 (Usd Million)
List Of Figures: Figure 1 North America Tumor Ablation Market: Segmentation; Figure 2 North America Tumor Ablation Market: Data Triangulation; Figure 3 North America Tumor Ablation Market: Droc Analysis; Figure 4 North America Tumor Ablation Market: North America Vs Regional Market Analysis; Figure 5 North America Tumor Ablation Market: Company Research Analysis; Figure 6 North America Tumor Ablation Market: Interview Demographics; Figure 7 North America Tumor Ablation Market: Market End Users Coverage Grid; Figure 8 North America Tumor Ablation Market: Dbmr Market Position Grid; Figure 9 North America Tumor Ablation Market: Vendor Share Analysis; Figure 10 North America Tumor Ablation Market: Segmentation; Figure 11 The Rising Prevalence Of Cancer And Growing Demand For Minimally Invasive Procedures Are Expected To Drive The Growth Of The North America Tumor Ablation Market From 2023 To 2030; Figure 12 The Thermal Ablation Segment, Is Expected To Account For The Largest Share Of The North America Tumor Ablation Market In 2023 & 2030; Figure 13 Drivers, Restraints, Opportunities And Challenges Of The North America Tumor Ablation Market; Figure 14 North America Tumor Ablation Market: By Type, 2022; Figure 15 North America Tumor Ablation Market: By Type, 2023-2030 (Usd Million); Figure 16 North America Tumor Ablation Market: By Type, Cagr (2023-2030); Figure 17 North America Tumor Ablation Market: By Type, Lifeline Curve; Figure 18 North America Tumor Ablation Market: By Types Of Treatment, 2022; Figure 19 North America Tumor Ablation Market: By Types Of Treatment, 2023-2030 (Usd Million); Figure 20 North America Tumor Ablation Market: By Types Of Treatment, Cagr (2023-2030); Figure 21 North America Tumor Ablation Market: By Types Of Treatment, Lifeline Curve; Figure 22 North America Tumor Ablation Market: By Cancer Type, 2022; Figure 23 North America Tumor Ablation Market: By Cancer Type, 2023-2030 (Usd Million); Figure 24 North America Tumor Ablation Market: By Cancer Type, Cagr (2023-2030); Figure 25 North America Tumor Ablation Market: By Cancer Type, Lifeline Curve; Figure 26 North America Tumor Ablation Market: By End Users, 2022; Figure 27 North America Tumor Ablation Market: By End Users, 2023-2030 (Usd Million); Figure 28 North America Tumor Ablation Market: By End Users, Cagr (2023-2030); Figure 29 North America Tumor Ablation Market: By End Users, Lifeline Curve; Figure 30 North America Tumor Ablation Market: By Distribution Channel, 2022; Figure 31 North America Tumor Ablation Market: By Distribution Channel, 2023-2030 (Usd Million); Figure 32 North America Tumor Ablation Market: By Distribution Channel, Cagr (2023-2030); Figure 33 North America Tumor Ablation Market: By Distribution Channel, Lifeline Curve; Figure 34 North America Tumor Ablation Market: Snapshot (2022); Figure 35 North America Tumor Ablation Market: By Country (2022); Figure 36 North America Tumor Ablation Market: By Country (2023 & 2030); Figure 37 North America Tumor Ablation Market: By Country (2022 & 2030); Figure 38 North America Tumor Ablation Market: By Type (2023-2030); Figure 39 North America Tumor Ablation Market: Company Share 2022 (%)